@FierceMedDev: Alere declares victory in proxy challenge. Article | Follow @FierceMedDev
@DamianFierce: Losses mounting, Invacare sells off another unit for $45M. Story | Follow @DamianFierce
@MichaelGFierce: Luminex axing 5% of workforce as reimbursement dries up. Article | Follow @MichaelGFierce
> Theragenics ($TGX) reported an 8% drop in revenue and another net loss in the second quarter, all as the company waits to be acquired by Juniper for a reported $68 million. Results
> Hologic ($HOLX) has launched a new bone imaging system used to assess osteoporosis, cardiovascular disease and obesity. Release
> Cook Medical has completed enrollment in a study of a new vascular access technique to treat peripheral artery disease. News
> GenMark Diagnostics ($GNMK) snagged $5.2 million in revenue last quarter, a 44% increase, but increased its net loss 42.8% to $8 million. More
> Kips Bay Medical ($KIPS) is enrolling an FDA-targeted trial for its external saphenous vein graft device, designed for use in coronary artery bypass surgeries. Item
> DexCom's ($DXCM) revenue jumped 65% to $35.5 million last quarter, and the diabetes device outfit narrowed its net loss by about 31% to $10.1 million. Financials
Biotech News
@FierceBiotech: Ousted scientist fires back at GSK's high-pressure R&D strategy in China. Story | Follow @FierceBiotech
@JohnCFierce: Is the silly season on biotech IPOs over? No, Intrexon debuts with $2B market value. Item | Follow @JohnCFierce
@RyanMFierce: Biotech M&A gossip: Amgen buyout of Onyx could happen soon. More | Follow @RyanMFierce
@EmilyMFierce: NIH to open genomic data of HeLa cells to researchers. Article | Follow @EmilyMFierce
> GlaxoSmithKline wires up $50M VC fund for bioelectronic treatment effort. Report
> Array slashes staff as Amgen pulls the plug on diabetes drug pact. News
Pharma News
@FiercePharma: Tyson suspends use of Merck growth enhancer for cattle b/c some having difficulty walking. Merck says Zilmax safe. Item | Follow @FiercePharma
@CarlyHFierce: ICYMI: On Vivus' Q2 earnings and plans from new CEO Tony Zook (formerly of AstraZeneca) to increase Qsymia sales. More | Follow @CarlyHFierce
> Sanofi faces bribery allegations from China whistleblower. Story
> Wanted: Buyers for Aptalis Pharma. Must be willing to pay $3B-plus. Article
> Endo invests big in Qualitest to push generic growth. More
Vaccines News
> Flu vaccine tablet developer raises $20M. News
> PharmAthene to add antibody assets in Theraclone merger. Item
> Sanofi advances C. diff vaccine into PhIII. More
> Israel buys 500,000 polio vaccines for immunization push. Article
> GSK adding 2-D barcode to 4-in-1 flu vaccine packaging. Story
> Dana-Farber sees promise in leukemia vaccine trial. More
Pharma Manufacturing News
@EricPFierce: Pharma Tech Industries to expand facility in Missouri. Story | Follow @EricPFierce
> GAO report says FDA needs clear authority over compounders. News
> Ranbaxy gets site for second Malaysian plant. Story
> When it comes to Viagra, counterfeiters just can get enough. Article
> Endo investing $100M in Qualitest manufacturing. More
> Recall expert takes services to Europe. Item